{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "FDA Announces Facility Fees for OTC Drug Manufacturers",
    "url": "https://www.lexblog.com/2021/03/29/facility-fees/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-RH0SCNXT",
        "url": "https://www.lexblog.com/lib/RH0SCNXT/"
    },
    "datePublished": "2021-03-29T15:40:02-04:00",
    "dateModified": "2024-01-25T15:23:21-05:00",
    "author": {
        "@type": "Person",
        "name": "Theresa Thompson"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Sheppard, Mullin, Richter & Hampton LLP"
    },
    "organizationScope": "at-publication",
    "about": "Food, Drug & Agriculture",
    "sourceUrl": "https://www.fdalawblog.com/?p=1766",
    "sourceStability": "may-move"
}